Objective: To assay drugs that modify pigmentation (ie, agents that ei
ther enhance or decrease pigmentation) in a predictive in vitro model,
as such drugs have been previously studied in vivo on human and anima
l skin. Design: An epidermis was reconstructed with human keratinocyte
s and melanocytes. Epidermal reconstructs with melanocytes were made a
ccording to a variant of the model of Prunieras and colleagues. Reagen
ts that alter melanogenesis such as isobutyl methylxanthine, 1-oleoyl-
2-acetyl-sn-glycerol, kojic acid, and mequinol were introduced in the
culture medium or used topically after 8 days of culture at the air-li
quid interface. Main Outcome Measurer: Macroscopic, colorimetric, hist
ological (Fontana-Masson stain and dopa reaction), and biochemical stu
dies were performed. Results: The effect of pigment modifiers was demo
nstrated ex vivo as expected from in vivo data on skin color, numbers
of melanocytes, melanosome transfer, and melanin content. Conclusion:
These results will permit other investigators to use this model to ass
ess the efficacy of novel molecules that alter pigmentation.